Use of Metabolomics to Phenotype and Categorize Risk in Human Health Studies Accelerates Clinical Care and Drug Development

Nontargeted metabolomics and both genome-wide association study (GWAS) and whole genome sequencing (WGS) approaches were used to identify genetic variants that modify the blood metabolome to identify signatures of human disease.

Presented at: Gordon Research Conference – Metabolomics and Human Health
March 12-15, 2023